Chicago Partners Investment Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$793K Buy
8,841
+1,984
+29% +$174K 0.02% 766
2026
Q1
$638K Buy
6,857
+3,190
+87% +$293K 0.01% 747
2025
Q4
$318K Sell
3,667
-493
-12% -$46.7K 0.01% 997
2025
Q3
$421K Buy
4,160
+295
+8% +$29.2K 0.01% 796
2025
Q2
$376K Buy
3,865
+124
+3% +$12K 0.01% 734
2025
Q1
$352K Buy
3,741
+530
+17% +$56.7K 0.01% 634
2024
Q4
$326K Sell
3,211
-9
-0.3% -$966 0.01% 630
2024
Q3
$337K Buy
3,220
+277
+9% +$30.2K 0.01% 592
2024
Q2
$328K Buy
2,943
+5
+0.2% +$589 0.01% 568
2024
Q1
$357K Buy
2,938
+44
+2% +$5.5K 0.02% 529
2023
Q4
$349K Buy
2,894
+92
+3% +$10.3K 0.02% 508
2023
Q3
$295K Buy
2,802
+138
+5% +$17.5K 0.02% 515
2023
Q2
$342K Buy
+2,664
New +$362K 0.02% 503
2018
Q4
Sell
-103
Closed -$12K 939
2018
Q3
$12K Buy
+103
New +$12.2K ﹤0.01% 783
2016
Q1
Sell
-1,449
Closed -$144K 495
2015
Q4
$144K Buy
+1,449
New +$142K 0.07% 190

Other funds holding ZBH

Chicago Partners Investment Group's ZBH Position: Q2 2026 in Review

Chicago Partners Investment Group increased its Zimmer Biomet (ZBH) stake by 29% in Q2 2026, buying an estimated $174K and bringing the position to 8,841 shares worth $793K. The position accounts for 0.02% of the portfolio, ranked #766.

Chicago Partners Investment Group first reported a position in ZBH in Q4 2015 and has held it in 15 quarters since. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Chicago Partners Investment Group held 8,841 shares of Zimmer Biomet worth $793K as of Q2 2026.
  • Chicago Partners Investment Group bought 1,984 Zimmer Biomet shares in Q2 2026, an estimated $174K.
  • Zimmer Biomet made up 0.02% of Chicago Partners Investment Group's portfolio in Q2 2026, its #766 holding.
  • Chicago Partners Investment Group first reported a position in Zimmer Biomet in Q4 2015 and has held it in 15 quarters since.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.